Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Female Pelvic Fistulae.
Serna-Gallegos T, Jeppson PC. Serna-Gallegos T, et al. Obstet Gynecol Clin North Am. 2021 Sep;48(3):557-570. doi: 10.1016/j.ogc.2021.05.008. Obstet Gynecol Clin North Am. 2021. PMID: 34416937 Review.
Evaluation of clear cell subtypes of ovarian and uterine malignancies with anti-PD-L1 and anti-PD1 immunohistochemical expression and their association with stage and survival.
Alldredge J, Serna-Gallegos T, Gallegos N, VanLeer JP, Chang J, Ziogas A, Goreal W, Randall L. Alldredge J, et al. Among authors: serna gallegos t. Gynecol Oncol. 2019 Dec;155(3):483-488. doi: 10.1016/j.ygyno.2019.10.008. Epub 2019 Oct 22. Gynecol Oncol. 2019. PMID: 31653509 Free PMC article. No abstract available.
Erratum to "Evaluation of clear cell subtypes of ovarian and uterine malignancies with anti-PD-L1 and anti-PD1 immunohistochemical expression and their association with stage and survival" [Gynecol. Oncol. 155 (2019) 483-488].
Alldredge J, Serna-Gallegos T, Gallegos N, VanLeer JP, Chang J, Ziogas A, Goreal W, Randall L. Alldredge J, et al. Among authors: serna gallegos t. Gynecol Oncol. 2020 Apr;157(1):299. doi: 10.1016/j.ygyno.2020.02.013. Epub 2020 Feb 12. Gynecol Oncol. 2020. PMID: 32059865 Free PMC article. No abstract available.
Risk Factors for De Novo Overactive Bladder After Midurethral Sling.
Serna-Gallegos T, Dutta S, Crowder C, Wadensweiler P, Whitcomb EL, Guaderrama NM. Serna-Gallegos T, et al. Urogynecology (Phila). 2024 Jan 1;30(1):59-64. doi: 10.1097/SPV.0000000000001380. Epub 2023 Jun 14. Urogynecology (Phila). 2024. PMID: 37326287
12 results